Kuala Lumpur, 06 May 2021

Amidst growing concern over Malaysia possibly entering the fourth wave of the COVID-19 pandemic, Allianz Malaysia Berhad (Allianz Malaysia), launched Allianz Careline, a dedicated telehealth support powered by Sunway Medical Centre.

Allianz Careline, which is an initiative under the Allianz We Care Community, aims to provide professional medical advice regarding COVID-19 symptoms or vaccines and any health related concerns remotely for the people.

Allianz Life Insurance Malaysia Berhad Chief Executive Officer, Joseph Gross said the company continues to uphold its promise of providing assurance and protection for Malaysians in the fight against the COVID-19 pandemic.

“Last year, the Allianz We Care Community was set up to support and reassure Malaysians in times of uncertainty. We are now in the second year of COVID-19 but there is no getting used to this unprecedented pandemic.

“Many questions are being raised not only on the pandemic, but on the vaccines and their side effects as well. As such, we aim to provide them with the necessary support and reassurance in the fastest, most convenient way possible through Allianz Careline,” he said.

Sunway Medical Centre Chief Executive Officer, Bryan Lin Boon Diann said, “In support of Allianz Careline, we pride the credibility of our Telehealth services as all medical or clinical enquiries will be attended by a certified nurse or medical officer. 

“We believe that necessity is the mother of innovation and as the healthcare industry evolves, we too must move in tandem to meet growing needs. This is also timely given the current pandemic situation. We aim to make the patient experience better and in turn improve health outcomes, which is the primary goal of all health services. With this service in tow, we will be able to provide easier, more efficient access to healthcare when and where the patient needs it.”

In mid-April 2021, Malaysia started to record over 2,000 positive cases daily, after reporting a decline in the number of cases since February this year where the country posted over 4,000 positive cases daily.

The growing number leads to questions such as vaccines efficacy and effectiveness, which requires answers from medical professionals. 

“With the Allianz Careline, medical professionals are only one call or text away. Our customers do not have to worry about social distancing in a crowd or traffic. Our partner Sunway Medical Centre is not only committed to providing care for people during this COVID-19 pandemic, but is also experienced in providing telehealth support,” Gross said. 

Allianz Malaysia is the first insurer to partner with Sunway Medical Centre for a holistic outreach on medical-related queries and concerns.

Gross said the Allianz Careline is also an initiative by the company to support the National Immunisation Programme which was rolled out by the government in February this year.

The Allianz Careline is available from Monday to Friday (except public holidays), from 10:00am to 8:00pm via call at 1-300-88-8822 or WhatsApp message at +6019 2212 398.

The dedicated telehealth support is one of the many healthcare and lifestyle benefits, in addition to the free COVID-19 coverage offered by Allianz We Care Community, which includes cash relief upon diagnosis of COVID-19, and hospitalisation and death benefit due to COVID-19.

The initiative is open to not only Allianz Malaysia’s own customers but also to non-customers (Malaysians aged 18 and above) at no cost. 

For non-Allianz Malaysia customers, the cash aid for COVID-19 diagnosis and hospitalisation is RM1,000 and death benefit is set at RM8,000. Allianz Malaysia customers will be able to make the most of the Premium category (up to RM6,000 in cash relief; up to RM20,000 lump sum death benefit) or Advanced category (up to up to RM4,000 in cash relief; up to RM20,000 lump sum death benefit). 

To register to be part of the Allianz We Care Community, visit 
Allianz We Care Community and fill out your personal details. 

 

Disclaimer: All information provided is true and correct at the time of publication